DSE:PHENIXINS

Phoenix Insurance PLC. announcements

366 Dhaka Stock Exchange announcements for Phoenix Insurance PLC. (PHENIXINS) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (24).

  1. Name Change of the Company

    Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'Phoenix Insurance PLC.' instead of 'Phoenix Insurance Company Limited' with effect from December 22, 2025. Other information (except name) will remain unchanged.

  2. Q3 Financials

    (Q3 Un-audited): EPS was Tk. 0.93 for July-September 2025 as against Tk. 0.59 for July-September 2024; EPS was Tk. 1.61 for January-September 2025 as against Tk. 1.22 for January-September 2024. NOCFPS was Tk. 0.77 for January-September 2025 as against Tk. 0.52 for January-September 2024. NAV per share was Tk. 33.95 as on September 30, 2025 and Tk. 33.98 as on September 30, 2024. (cont.) (Cont. News of PHENIXINS): Reasons for deviation: Earnings Per Share (EPS) increased due to increase in gross premium, investment and others income. Net Operating Cash Flow Per Share (NOCFPS) is higher due to collection from premium and other income increased. (end)

  3. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 29, 2025 at 4:30 PM to consider, among others, Un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2025.

  4. Board decision to sell company's 8th storied commercial building

    The company has informed that the Board of Directors of the company in its meeting held 24th September 2025 has decided to sell the 8th storied commercial building measuring 8.61 katha (joint owner 50:50 i.e., Phoenix Insurance and Phoenix Finance) named "Phoenix Bhaban" at 12 Dilkusha C/A, Dhaka-1000 to enhance the invest income by diversifying the investments and meet up other liabilities of the company.

  5. Dividend Disbursement

    The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2024 to the respective shareholders.

  6. Q2 Financials

    (Q2 Un-audited): EPS was Tk. 0.29 for April-June 2025 as against Tk. 0.15 for April-June 2024; EPS was Tk. 0.68 for January-June 2025 as against Tk. 0.63 for January-June 2024. NOCFPS was Tk. (0.97) for January-June 2025 as against Tk. 0.11 for January-June 2024. NAV per share was Tk. 33.13 as on June 30, 2025 and Tk. 33.83 as on June 30, 2024. (cont.) (Continuation news of PHENIXINS): EPS increased due to decreased in reinsurance cost, management expenses & claims. NOCFPS is lower due to collection from premium & other income decreased. (end)

  7. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 31, 2025 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2025.

  8. Appointment of Company Secretary

    The company has informed that as per the decision of 411st Board meeting Mr. Chowdhury Akram Ullah, Vice President, Board Department of Head Office has been given the charge of the Company Secretary of the company.

  9. Emphasis of Matter

    The auditor of the company has given the "Emphasis of Matter" paragraphs in the Auditor's Report of the company for the year ended December 31, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/PHENIXINS_2024.pdf

  10. Credit Rating Result

    ARGUS Credit Rating Services Limited (ACRSL) has announced the CPA (Claim Paying Ability) rating of the Company as "AAA" in the long term and "ST-1" in the short term along with Stable outlook in consideration of financials of the company up to December 31, 2024 (audited), Q1FY25 (unaudited) and other relevant quantitative as well as qualitative information up to the date of rating declaration.

  11. Resumption after Record Date

    Trading of the shares of the company will resume on 04.06.2025.

  12. Suspension for Record Date

    Trading of the shares of the company will remain suspended on the record date, i.e., 03.06.2025.

  13. PHOENIXINS: Spot News

    Trading of the shares of the company will be allowed only in the Spot Market and Block transactions will also be settled as per the spot settlement cycle with cum benefit from 01.06.2025 to 02.06.2025, and trading of the shares will remain suspended on the record date i.e., 03.06.2025.

  14. Dividend Declaration

    The Board of Directors has recommended 10% Cash Dividend for the year ended December 31, 2024. Date of AGM: 23.07.2025, Time: 03:00 PM, Venue: Digital Platform. Record Date: 03.06.2025. The Company has also reported EPS of Tk. 1.51, NAV per share of Tk. 32.42 and NOCFPS of Tk. 0.22 for the year ended December 31, 2024 as against Tk. 1.59, Tk. 37.23 and Tk. 0.75 respectively for the year ended December 31, 2023. Reasons for deviation in EPS, NAV per share and NOCFPS: (cont.) (cont. news of PHENIXINS): The company's EPS decreased due to revenue income have been decreased from last year. NAV per share decreased due to investment have been decreased from last year. NOCFPS is lower due to reinsurance and claim has been decreased from last year. (end)

  15. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (06.05.2025) following its corporate declaration.

  16. Q1 Financials

    (Q1 Un-audited): EPS was Tk. 0.39 for January-March 2025 as against Tk. 0.48 for January-March 2024. NOCFPS was Tk. 0.07 for January-March 2025 as against Tk. 0.92 for January-March 2024. NAV per share was Tk. 33.32 as on March 31, 2025 and Tk. 35.27 as on March 31, 2024. Reasons for deviation in EPS, NAV per share and NOCFPS: (cont.) (cont. news of PHENIXINS): The company's EPS decreased due to premium and other income have been decreased. NAV per share increased due to investment have been increased from last year. NOCFPS is lower due to collection from premium and other income have been decreased from last year. (end)

  17. Reschedule of Board Meeting under LR 19(1)

    The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on May 05, 2025 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.

  18. Reschedule of Board Meeting under LR 16(1)

    The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on May 05, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025.

  19. Postponement of Board Meeting schedule under LR 19(1)

    The Company has further informed that due to unavoidable circumstances, the meeting scheduled to be held on April 30, 2025 at 4:00 PM as per LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, audited financial statements of the Company for the year ended December 31, 2024, has been postponed. New date and time of the meeting will be notified later.

  20. Postponement of Board Meeting schedule under LR 16(1)

    The Company has further informed that due to unavoidable circumstances, the meeting scheduled to be held on April 30, 2025 at 3:00 PM as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025, has been postponed. New date and time of the meeting will be notified later.

  21. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025.

  22. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2025 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.

  23. Appointment of Chief Executive Officer

    The company has informed that as per approval of Insurance Development and Regulatory Authority (IDRA), the Board of Directors of the company has appointed Mr. Md. Rafiqur Rahman as Chief Executive Officer (CEO) of the company.

  24. Address Change of Head Office

    The company has informed that the head office of the company has been relocated to the following address: Phoenix Tower (Level-5), 407, Tejgaon Industrial Area, Dhaka-1208, with effect from March 02, 2025.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.